| Date | Form | Description | Docs | XBRL | Pages |
| 03/09/20 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
35 |
| 01/21/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 01/16/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 01/15/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 01/14/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 01/10/20 | 10-K/A | Annual report pursuant to Section 13 and 15(d) |
|
110 | |
| 01/09/20 | 424B3 | Prospectus filed pursuant to Rule 424(b)(3) |
|
4 | |
| 01/09/20 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
|
128 |
| 12/16/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 12/16/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |
Latest News & Events
Anixa Biosciences to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference on May 20th
Read More...Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for CAR-T Technology, Further Strengthening its Robust Intellectual Property Portfolio
Read More...Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for Patent Covering Breast Cancer Vaccine Technology
Read More...